CANCER GENETICS
UPDATES ON TESTING, PREVENTION, AND TREATMENT
June 20, 2020
POSTPONED
Greehey Children's Cancer Research Institute, San Antonio, Texas
We are closely monitoring the COVID-19 situation and actively working with UT Health System to ensure authoritative communication of safety updates and recommendations as the situation evolves.
about
Target Audience: This conference is intended for Physicians, Nurse Practitioners, Physician Assistants, Nurses, specialists in Internal Medicine, Surgery, and Genetic Counseling, students, and fellows.
Purpose and Content: This conference is focused on updating health professionals on the current practices of cancer genetics. Topics will include general genetics knowledge, updates on genetic syndromes and management, genetic counseling and testing strategies, population screening, ethical/ legal issues surrounding genetic testing and results, and new genetic tests being offered and their benefits and limitations. After attending, the participant should leave with a better understanding of hereditary predisposition syndromes, management guidelines, and testing criteria. This conference will aid healthcare professionals in their practices and improve patient care.
Educational Objectives: Upon completion of this conference, participants should be able to link the educational objectives to Core Competencies and:
- Apply basic genetic concepts in discussions with patients
- Recognize patients appropriate for referral to cancer genetics
- Discuss updated testing strategies and management guidelines for patients at risk for hereditary breast, colon, prostate, gynecological, and pediatric cancers
- Identify patients who may benefit from tumor genomic testing or germline testing to introduce new therapeutic options.
- Identify and discuss the differences between laboratory tests as well as the different options associated with ordering genetic testing.
- Identify insurance fraud and inappropriate testing and what to do about it
- Discuss new systemic therapies for hereditary cancer syndromes
program
Continuing education
The Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™
Speakers
Sukeshi Arora, MD
UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Banu Arun, MD
UT MD Anderson Cancer Center, Houston, TX
Virginia Kaklamani, MD
UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Edward Kost, MD
UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Chethan Ramamurthy, MD
UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Anusha Vaidyanathan, CGC
UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Conflict of Interest
All persons involved with the content of this conference, as well as, speakers and presenters, are required to disclose all relevant conflicts of interest, including: any financial relationships, marketing, re-selling, or distributing health care goods or services.
Discussion of Off-Label Use
This course is meant to educate physicians with what is currently in use and what may be available in the future. There may be “off-label” use discussed in the activity. Speakers have been requested to inform the audience when off-label used is discussed.
REGISTRATION
$300
Industry Representatives
$75
Physicians
$40
Nurses
$25*
Students
*With valid Student ID
Payment
Accepted payment methods for registration are AMEX, Visa/Mastercard and Discover, check, wire transfer/ACH, IDT: Inter-Departmental Transfer (UT Health San Antonio only). The Symposia office does not accept third party payment methods such as SAP Ariba, EVED or Purchase Orders.
Cancellation and Refund Policy
You
must contact the Symposia office no later than June 12, 2020 to
cancel your registration. For cancellations made by June 12, 2020,
your registration will be refunded less a $25 cancellation fee. No refunds
after June 12, 2020.
UT Health continues to monitor the Coronavirus (COVID-19). As the global impact of COVID-19 grows daily, our priority is always on the health and safety of our community. In the event that the 2020 Cancer Genetics: Updates on Testing, Prevention, and Treatment is cancelled, registration fees will be refunded in full.
Program Accessibility
Program Accessibility: We are committed to accommodating the needs of individuals with disabilities in accordance with the Americans with Disabilities Act. Please contact us at 210-450-1550 if you have any questions or concerns.
Due to liability restrictions and concerns, children under eighteen years of age may not participate in any part of this conference.
SUPPORT & EXHIBITS
The Cancer Genetics: Updates on Testing, Prevention, and Treatment welcomes support from industry, corporations and other organizations that share its mission on providing healthcare professionals information to include general genetics knowledge, updates on genetic syndromes and management, genetic counseling and testing strategies, population screening, ethical/ legal issues surrounding genetic testing and results, and new genetic tests being offered and their benefits and limitations.
Educational Grants
Support for general educational programming costs. The Symposia office uses grant funds to defray expenses associated with educational activities in compliance with the ACCME guidelines. If your company or organization offers educational grants in support of CME accredited educational activities related to cancer genetics, we would appreciate receiving the grant application information. Please contact the Symposia office at UTHealthMTG@uthscsa.edu or 210-450-1550.
Support
We welcome any amount of support for this conference which will be used to defray operating costs to support the Cancer Genetics: Updates on Testing, Prevention, and Treatment. Please view the sponsorship option below:
Mobile App Advertising: $500 - one available
- The mobile app has over 150 users that will view your corporate brand ad on the dashboard. When the brand ad is tapped it will go to a URL site of your choice. Your company will be acknowledged on the Cancer Genetics: Updates on Testing, Prevention, and Treatment Website and on-site signage.
Exhibits
A limited number of exhibit tables are available. UT Health San Antonio MD Anderson Cancer Center uses exhibit fees to defray non-educational operating expenses.
6' X 3' table: $2000
Includes:
- Two complimentary registrations
- Lead management
Payments
Upon receipt of your completed Support/Exhibit Application we will send an invoice payable in 30 days (Due upon receipt if your invoice is issued on/after May 1). The Symposia office accepts check, credit card and wire transfer payments. We do not accept third party payment methods such as SAP Ariba, EVED or Purchase Orders for support payments. Upon receiving payment, exhibit space will be assigned to each company. Also considered are such factors as preferred placement away from or near another exhibitor. Please note that although we will make every effort to accommodate your preference, placement according to preference is not guaranteed.
UT Health San Antonio is a not-for-profit organization, and the tax ID is 74-1586031.
UT Health continues to monitor the Coronavirus (COVID-19). As the global impact of COVID-19 grows daily, our priority is always on the health and safety of our community. In the event that the 2020 Cancer Genetics: Updates on Testing, Prevention, and Treatment is cancelled, fees will be refunded in full.
LOCATION
Greehey Children's Cancer Research Institute
Greehey Auditorium
8403 Floyd Curl Drive
San Antonio, TX 78229
connect with us
UT Health San Antonio MD Anderson Cancer Center
7979 Wurzbach Road, MC 8224
San Antonio, TX 78229
P: (210) 450-1550 F: (210) 450-1560
WE MAKE LIVES BETTER®
We're part of the UT Health San Antonio, provider of comprehensive health, dental & cancer care, advanced academics and life-saving research.